1. Eli Lilly and Company (NYSE:LLY)
Number of Hedge Fund Holders: 137
Eli Lilly and Company (NYSE:LLY) is among the best healthcare stocks.
TheFly reported on April 10 that Morgan Stanley increased its price target on LLY to $1,327 from $1,313 while maintaining an Overweight rating. The update reflects revised financial models across the firm’s biopharmaceutical coverage. The adjustments incorporate recent IQVIA industry data trends along with intra-quarter performance updates ahead of upcoming first-quarter earnings across the sector.
Additionally, on April 13, Eli Lilly and Company (NYSE:LLY) reported positive topline results from its Phase 3 BRUIN CLL-322 study evaluating Jaypirca (pirtobrutinib) in combination with venetoclax and rituximab in patients with relapsed or refractory CLL/SLL. The trial met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival compared with the control regimen of venetoclax plus rituximab. Benefits were observed consistently across key patient subgroups, regardless of prior exposure to covalent BTK inhibitors.
Overall survival data remained immature but showed an early, favorable trend for the combination therapy. Safety findings were generally consistent with known profiles of the individual drugs, with similar adverse event rates and low discontinuation levels across both study arms. The results support potential future regulatory submissions and further evaluation of Jaypirca in earlier-line combination treatment settings.
Eli Lilly and Company (NYSE:LLY) is a global pharmaceutical company that develops and markets medicines for diabetes, oncology, immunology, and neuroscience. It is known for innovative drug development and treatments such as insulin therapies, obesity, and cancer medications.
While we acknowledge the risk and potential of LLY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than LLY and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 10 Best Mid Cap Stocks to Invest In According to Billionaires and 10 Best Cheap Stocks Under $10 to Buy in April.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
